Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
- PMID: 39202297
- PMCID: PMC11353460
- DOI: 10.3390/diagnostics14161809
Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
Abstract
Medullary thyroid cancer (MTC) shows a relatively poor prognosis among thyroid cancers. Though calcitonin has been used as a diagnostic marker for MTC, it has disadvantages including poor sample stability and discrepancies among results by assay. This study aimed to compare the usefulness of preoperative calcitonin and procalcitonin (PCT) in the diagnosis of MTC. Serum calcitonin and PCT levels were measured before thyroidectomy from MTC (n = 23) and other types of thyroid cancers in patients (n = 1308). Diagnostic performances of calcitonin and PCT for discerning MTC were estimated. In a multivariate analysis, preoperative calcitonin level was independently associated with the diagnosis of MTC, whereas PCT was not. Calcitonin and PCT, respectively, exhibited area under the curve values of 0.997 and 0.979 for the diagnosis of MTC, without significant differences. For calcitonin, the sensitivity, specificity, and positive and negative predictive values were 0.957, 0.992, 0.688, and 0.999, respectively, at a cut-off of 7.2 pg/mL. The corresponding values for PCT were 0.913, 0.995, 0.778, and 0.998 at a cut-off of 0.19 ng/mL. Preoperative calcitonin and PCT showed similar diagnostic utility for MTC. Depending on the patient's clinical status and laboratory environment, these tests can be used as complementary methods for detecting MTC.
Keywords: calcitonin; diagnostic performance; medullary thyroid cancer; procalcitonin.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma.Clin Chem Lab Med. 2020 Oct 22;59(4):743-747. doi: 10.1515/cclm-2020-1424. Print 2021 Mar 26. Clin Chem Lab Med. 2020. PMID: 33085633
-
Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.Eur J Clin Invest. 2018 Jun;48(6):e12934. doi: 10.1111/eci.12934. Epub 2018 Apr 20. Eur J Clin Invest. 2018. PMID: 29635700 Free PMC article.
-
Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.J Clin Endocrinol Metab. 2009 Mar;94(3):861-8. doi: 10.1210/jc.2008-1862. Epub 2008 Dec 16. J Clin Endocrinol Metab. 2009. PMID: 19088163 Free PMC article.
-
Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.J Pediatr Endocrinol Metab. 2021 Sep 21;34(12):1491-1504. doi: 10.1515/jpem-2021-0163. Print 2021 Dec 20. J Pediatr Endocrinol Metab. 2021. PMID: 34543539 Review.
-
Diagnostic challenges in calcitonin negative medullary thyroid carcinoma: a systematic review of 101 cases.Gland Surg. 2024 Oct 31;13(10):1785-1804. doi: 10.21037/gs-24-292. Epub 2024 Oct 26. Gland Surg. 2024. PMID: 39544965 Free PMC article. Review.
Cited by
-
Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease.Diagnostics (Basel). 2025 Jun 3;15(11):1418. doi: 10.3390/diagnostics15111418. Diagnostics (Basel). 2025. PMID: 40506990 Free PMC article. Review.
-
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.Int J Mol Sci. 2025 May 28;26(11):5173. doi: 10.3390/ijms26115173. Int J Mol Sci. 2025. PMID: 40507982 Free PMC article. Review.
-
Procalcitonin: Infection or Maybe Something More? Noninfectious Causes of Increased Serum Procalcitonin Concentration: Updated Knowledge.Life (Basel). 2025 Mar 12;15(3):446. doi: 10.3390/life15030446. Life (Basel). 2025. PMID: 40141790 Free PMC article. Review.
-
Limited Thyroidectomy Achieves Equivalent Survival to Total Thyroidectomy for Early Localized Medullary Thyroid Cancer.Cancers (Basel). 2024 Dec 4;16(23):4062. doi: 10.3390/cancers16234062. Cancers (Basel). 2024. PMID: 39682246 Free PMC article.
References
LinkOut - more resources
Full Text Sources